The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to ly-ester TSA201719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester TSA201758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester TSA201799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester TSA201841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester TSA201883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester TSA201924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester TSA201963-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester TSA201996-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester TSF422756-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF422754-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF422755-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF422757-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF422758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF422759-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF423014-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF423015-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF423011-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF423012-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF423013-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF423016-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF423271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF423272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF423273-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF423274-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF423275-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF423276-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF423538-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF423539-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF423540-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF423541-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF423542-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF423543-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF423805-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF423806-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF423807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF423808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF423809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF423810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF424074-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF424071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF424070-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF424072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF424073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF424075-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF424332-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF424333-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF424334-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF424335-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF424336-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF424337-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSF424576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.12 µM for 24.0 h 1 subfactor(s) TSF424577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.37 µM for 24.0 h 1 subfactor(s) TSF424575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.04 µM for 24.0 h 1 subfactor(s) TSF424578-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 1.11 µM for 24.0 h 1 subfactor(s) TSF424579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 10.0 µM for 24.0 h 1 subfactor(s) TSF424580-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 3.33 µM for 24.0 h 1 subfactor(s) TSS422764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.37 µM for 24.0 h TSS422762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.04 µM for 24.0 h TSS422763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 0.12 µM for 24.0 h TSS422765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 1.11 µM for 24.0 h TSS422766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 10.0 µM for 24.0 h TSS422767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to ly-ester 3.33 µM for 24.0 h TSS423022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 1.11 µM for 24.0 h TSS423023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 10.0 µM for 24.0 h TSS423019-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.04 µM for 24.0 h TSS423020-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.12 µM for 24.0 h TSS423021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 0.37 µM for 24.0 h TSS423024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to ly-ester 3.33 µM for 24.0 h TSS423279-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.04 µM for 24.0 h TSS423280-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.12 µM for 24.0 h TSS423281-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 0.37 µM for 24.0 h TSS423282-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 1.11 µM for 24.0 h TSS423283-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 10.0 µM for 24.0 h TSS423284-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to ly-ester 3.33 µM for 24.0 h TSS423546-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.04 µM for 24.0 h TSS423547-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.12 µM for 24.0 h TSS423548-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 0.37 µM for 24.0 h TSS423549-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 1.11 µM for 24.0 h TSS423550-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 10.0 µM for 24.0 h TSS423551-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to ly-ester 3.33 µM for 24.0 h TSS423813-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.04 µM for 24.0 h TSS423814-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.12 µM for 24.0 h TSS423815-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 0.37 µM for 24.0 h TSS423816-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 1.11 µM for 24.0 h TSS423817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 10.0 µM for 24.0 h TSS423818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to ly-ester 3.33 µM for 24.0 h TSS424082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 10.0 µM for 24.0 h TSS424079-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.12 µM for 24.0 h TSS424078-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.04 µM for 24.0 h TSS424080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 0.37 µM for 24.0 h TSS424081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 1.11 µM for 24.0 h TSS424083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to ly-ester 3.33 µM for 24.0 h TSS424340-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.04 µM for 24.0 h TSS424341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.12 µM for 24.0 h TSS424342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 0.37 µM for 24.0 h TSS424343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 1.11 µM for 24.0 h TSS424344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 10.0 µM for 24.0 h TSS424345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to ly-ester 3.33 µM for 24.0 h TSS424584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.12 µM for 24.0 h TSS424585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.37 µM for 24.0 h TSS424583-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 0.04 µM for 24.0 h TSS424586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 1.11 µM for 24.0 h TSS424587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 10.0 µM for 24.0 h TSS424588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to ly-ester 3.33 µM for 24.0 h
TSP48711 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to ly-ester
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided